The safety and efficacy of clofarabine in combination with high-dose cytarabine and total body irradiation myeloablative conditioning and allogeneic stem cell transplantation in children, adolescents, and young adults (CAYA) with poor-risk acute leukemia-Reference-Cited by-同舟云学术

The safety and efficacy of clofarabine in combination with high-dose cytarabine and total body irradiation myeloablative conditioning and allogeneic stem cell transplantation in children, adolescents, and young adults (CAYA) with poor-risk acute leukemia

Published:2018-06-13 Issue:2 Volume:54 Page:226-235
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Hochberg Jessica,Zahler Stacey,Geyer Mark B.^ORCID,Chen Nan,Krajewski Jennifer,Harrison Lauren,Militano Olga,Ozkaynak M. Fevzi,Cheerva Alexandra C.^ORCID,Talano Julie,Moore Theodore B.,Gillio Alfred P.,Walters Mark C.,Baxter-Lowe Lee Ann,Hamby Carl,Cairo Mitchell S.

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/s41409-018-0247-9.pdf

Reference26 articles.

1. Reismuller B, Peters C, Dworzak MN, Potschger U, Urban C, Meister B, et al. Outcome of children and adolescents with a second or third relapse of acute lymphoblastic leukemia (ALL): a population-based analysis of the Austrian ALL-BFM (Berlin-Frankfurt-Munster) study group. J Pediatr Hematol Oncol. 2013;35:e200–204.

2. Faderl S, Gandhi V, O’Brien S, Bonate P, Cortes J, Estey E, et al. Results of a phase 1-2 study of clofarabine in combination with cytarabine (ara-C) in relapsed and refractory acute leukemias. Blood. 2005;105:940–7.

3. Kaspers G. How I treat paediatric relapsed acute myeloid leukaemia. Br J Haematol. 2014;166:636–45.

4. Thomas X, de Botton S, Chevret S, Caillot D, Raffoux E, Lemasle E, et al. Randomized phase II study of clofarabine-based consolidation for younger adults with acute myeloid leukemia in first remission. J Clin Oncol. 2017;35:1223–30.

5. Shereck EB, Cooney E, van de Ven C, Della-Lotta P, Cairo MS. A pilot phase II study of alternate day ganciclovir and foscarnet in preventing cytomegalovirus (CMV) infections in at-risk pediatric and adolescent allogeneic stem cell transplant recipients. Pediatr Blood Cancer. 2007;49:306–12.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Successful clofarabine desensitization in a pediatric patient with acute myeloid leukemia;Pediatric Allergy and Immunology;2021-12-14

2. Clofarabine increases the eradication of minimal residual disease of primary Bprecursor acute lymphoblastic leukemia compared to high-dose cytarabine without improvement of outcome;Haematologica;2021-08-05

3. Phase I/II multisite trial of optimally dosed clofarabine and low‐dose TBI for hematopoietic cell transplantation in acute myeloid leukemia;American Journal of Hematology;2019-11-08

4. First results of pilot protocol ALl-REZ-2016 for children with high risk groups of relapsed acute lymphoblastic leukemia;Pediatric Hematology/Oncology and Immunopathology;2019-04-21